BioScrip to Participate in Upcoming Investor Conferences
September 05 2018 - 9:00AM
BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the
largest independent national provider of infusion and home care
management solutions, today announced that Daniel E. Greenleaf,
President and Chief Executive Officer, will participate in the
following upcoming investor conferences:
The 2nd Annual Lake Street Best Ideas Growth (B.I.G.)
ConferenceNew York, New YorkThursday, September 13,
2018One-on-one meetings
The 11th Annual Barrington Research Fall Investment
Conference Chicago, IllinoisThursday, September 27,
2018One-on-one and small group meetings
Copies of materials used during the meetings will be accessible
via BioScrip’s Investor Relations website at
https://investors.bioscrip.com/.
About BioScrip, Inc.
BioScrip, Inc. is the largest independent
national provider of infusion and home care management solutions,
with approximately 2,100 teammates and nearly 70 service locations
across the U.S. BioScrip partners with physicians, hospital
systems, payors, pharmaceutical manufacturers and skilled nursing
facilities to provide patients access to post-acute care services.
BioScrip operates with a commitment to bring customer-focused
pharmacy and related healthcare infusion therapy services into the
home or alternate-site setting. By collaborating with the full
spectrum of healthcare professionals and the patient, BioScrip
provides cost-effective care that is driven by clinical excellence,
customer service, and values that promote positive outcomes and an
enhanced quality of life for those it serves.
Investor Contacts:
Stephen Deitsch
Kalle Ahl, CFAChief Financial
Officer & Treasurer
The Equity GroupT: (720) 697-5200
T:
(212) 836-9614stephen.deitsch@bioscrip.com
kahl@equityny.com
BioPlus Acquisition (NASDAQ:BIOS)
Historical Stock Chart
From Mar 2024 to Apr 2024
BioPlus Acquisition (NASDAQ:BIOS)
Historical Stock Chart
From Apr 2023 to Apr 2024